Physiology and Biophysics,
College of Medicine,
Physiology and Biophysics, College of Medicine
Jonna Frasor has not added Biography.
If you are Jonna Frasor and would like to personalize this page please email our Author Liaison for assistance.
Regulation of nuclear receptor transcriptional activity by a novel DEAD box RNA helicase (DP97).
The Journal of biological chemistry Feb, 2003 | Pubmed ID: 12466272
Prolactin regulation of estrogen receptor expression.
Trends in endocrinology and metabolism: TEM Apr, 2003 | Pubmed ID: 12670737
Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus.
Endocrinology Jul, 2003 | Pubmed ID: 12810572
Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype.
Endocrinology Oct, 2003 | Pubmed ID: 12959972
Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells.
Cancer research Feb, 2004 | Pubmed ID: 14973112
Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors.
Endocrinology Jul, 2004 | Pubmed ID: 15033914
Therapeutic targeting in the estrogen receptor hormonal pathway.
Seminars in oncology Feb, 2004 | Pubmed ID: 15052541
Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells.
Molecular endocrinology (Baltimore, Md.) Jun, 2005 | Pubmed ID: 15831524
Estrogen down-regulation of the corepressor N-CoR: mechanism and implications for estrogen derepression of N-CoR-regulated genes.
Proceedings of the National Academy of Sciences of the United States of America Sep, 2005 | Pubmed ID: 16141343
Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
Endocrinology Oct, 2006 | Pubmed ID: 16809442
Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome.
Cancer research Jul, 2006 | Pubmed ID: 16849584
Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation.
Molecular endocrinology (Baltimore, Md.) Sep, 2007 | Pubmed ID: 17550982
Structure-activity relationships for a family of benzothiophene selective estrogen receptor modulators including raloxifene and arzoxifene.
ChemMedChem Oct, 2007 | Pubmed ID: 17654759
Synergistic up-regulation of prostaglandin E synthase expression in breast cancer cells by 17beta-estradiol and proinflammatory cytokines.
Endocrinology Dec, 2008 | Pubmed ID: 18703630
Estrogenic effects of herbal medicines from Costa Rica used for the management of menopausal symptoms.
Menopause (New York, N.Y.) Jul-Aug, 2009 | Pubmed ID: 19424091
Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.
Cancer research Dec, 2009 | Pubmed ID: 19920189
Estrogenic and progestagenic effects of extracts of Justicia pectoralis Jacq., an herbal medicine from Costa Rica used for the treatment of menopause and PMS.
Maturitas Jul, 2010 | Pubmed ID: 20452152
Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NF{kappa}B cooperativity at adjacent response elements.
The Journal of biological chemistry Oct, 2010 | Pubmed ID: 20705611
Estrogen promotes breast cancer cell survival in an inhibitor of apoptosis (IAP)-dependent manner.
Hormones & cancer Jun, 2010 | Pubmed ID: 21152357
The stimulation of HSD17B7 expression by estradiol provides a powerful feed-forward mechanism for estradiol biosynthesis in breast cancer cells.
Molecular endocrinology (Baltimore, Md.) May, 2011 | Pubmed ID: 21372145
An integrated bioinformatics approach identifies elevated cyclin E2 expression and E2F activity as distinct features of tamoxifen resistant breast tumors.
PloS one , 2011 | Pubmed ID: 21789246
CBP mediates NF-κB-dependent histone acetylation and estrogen receptor recruitment to an estrogen response element in the BIRC3 promoter.
Molecular and cellular biology Jan, 2012 | Pubmed ID: 22083956
Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers.
Molecular endocrinology (Baltimore, Md.) Mar, 2012 | Pubmed ID: 22301780
14-3-3ζ as a predictor of early time to recurrence and distant metastasis in hormone receptor-positive and -negative breast cancers.
Breast cancer research and treatment Feb, 2013 | Pubmed ID: 23271328
Growth hormone potentiates 17β-estradiol-dependent breast cancer cell proliferation independently of IGF-I receptor signaling.
Endocrinology Sep, 2013 | Pubmed ID: 23782942
NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms.
Molecular and cellular endocrinology Dec, 2015 | Pubmed ID: 25450861
A novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties.
BMC cancer Nov, 2015 | Pubmed ID: 26530254
Dimethyl Fumarate Inhibits the Nuclear Factor κB Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein.
The Journal of biological chemistry Feb, 2016 | Pubmed ID: 26683377
Correlative Analysis of miRNA Expression and Oncotype Dx Recurrence Score in Estrogen Receptor Positive Breast Carcinomas.
PloS one , 2015 | Pubmed ID: 26717565
Full antagonism of the estrogen receptor without a prototypical ligand side chain.
Nature chemical biology Jan, 2017 | Pubmed ID: 27870835
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved